checkAd
    Startseite > Aktien > Virpax Pharmaceuticals > Nachrichten
    Virpax Pharmaceuticals Aktie
    3,0900
     
    USD
    +7,67 %
    +0,2200 USD
    Letzter Kurs 27.04.24 Nasdaq
    2,8600
     
    USD
    200 STK
    Geldkurs 26.04.24
    3,0900
     
    USD
    300 STK
    Briefkurs 26.04.24
    ISIN: US9282512063 · SYM: VRPX · USA

    Neueste Nachrichten

    Virpax Pharmaceuticals Reports 2023 Year-End Results
    26.03.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
    27.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
    27.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
    07.02.24 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Results of Special Shareholders Meeting
    29.12.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
    17.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals
     Virpax Pharmaceuticals Announces Leadership Transition
    17.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
    15.11.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces that Envelta Remains on Track for Trial in Humans Following FDA Review
    31.10.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
    12.10.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Gerald W. Bruce Appointed President and CEO of Novvae Pharmaceuticals
    02.10.23 · Business Wire (engl.) · Virpax Pharmaceuticals
    Virpax Pharmaceuticals Announces Results of Probudur Dose Escalation Studies
    27.09.23 · Business Wire (engl.) · Virpax Pharmaceuticals